MYUNGMOON Pharm co.,Ltd (KRX:017180)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,807.00
+3.00 (0.17%)
Apr 8, 2026, 3:30 PM KST
Market Cap60.30B +11.6%
Revenue (ttm)195.25B +4.7%
Net Income1.90B
EPS57.00
Shares Out33.43M
PE Ratio31.65
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,905
Average Volume91,090
Open1,808.00
Previous Close1,804.00
Day's Range1,798.00 - 1,824.00
52-Week Range1,412.00 - 2,055.00
Beta0.42
RSI47.28
Earnings DateMay 14, 2026

About MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics,... [Read more]

Sector Healthcare
Founded 1983
Employees 291
Stock Exchange Korea Stock Exchange
Ticker Symbol 017180
Full Company Profile

Financial Performance

Financial Statements